Evidence map›Paper›PMID 35403698›Full record

ArticleInternational journal of cancer2022

Hypothesised cutaneous sites of origin of stage III melanomas with unknown primary: A multicentre study.

Bethan Clayton, Ferhan Muneeb, Maria Celia B Hughes, Megan E Grant, Kiarash Khosrotehrani, B Mark Smithers, Romina Spina, Luca G Campana, Deemesh Oudit, Adele C Green

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in International journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Bethan ClaytonDepartment of Surgery, The Christie NHS Foundation Trust, Manchester, UK.
Ferhan MuneebDepartment of Surgery, The Christie NHS Foundation Trust, Manchester, UK.
Maria Celia B HughesPopulation Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Megan E GrantMolecular Oncology Group, CRUK Manchester Institute, University of Manchester, Manchester, UK.ORCID 0000-0002-5102-4120
Kiarash KhosrotehraniExperimental Dermatology Group, The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.ORCID 0000-0002-6406-4076
B Mark SmithersQueensland Melanoma Project, Princess Alexandra Hospital, The University of Queensland, Brisbane, Australia.
Romina SpinaDepartment of Surgery, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Luca G CampanaDepartment of Surgery, The Christie NHS Foundation Trust, Manchester, UK.
Deemesh OuditDepartment of Surgery, The Christie NHS Foundation Trust, Manchester, UK.
Adele C GreenPopulation Health Department, QIMR Berghofer Medical Research Institute, Brisbane, Australia.ORCID 0000-0002-2753-4841
The Christie NHS Foundation Trust · GBQIMR Berghofer Medical Research Institute · AUUniversity of Padua · ITThe University of Queensland · AUTranslational Research Institute · AUUniversity of Manchester · GB

Funding

Cancer Research UK A27412
6 · The paper itself

Abstract

Based on molecular evidence that melanomas with unknown primary (MUPs) arise from the skin, we hypothesised that sites of MUPs are disproportionately on trunk and lower limbs, sites that are not readily visible to patients and clinicians. We tested this hypothesis by inferring the anatomic site of origin of MUPs from the corresponding known cutaneous sites of melanoma patients with known primary tumours (MKPs). We analysed data from three separate cohorts of patients from Brisbane, Australia (n = 236); Manchester, UK (n = 51) and Padova, Italy (n = 33), respectively, who first presented with stage III melanoma with lymph node metastases. We matched two MKP patients to each MUP patient based on lymph node dissection (LND) site, age and sex, and imputed cutaneous sites of origin of MUPs from their two matched MKPs for study countries, giving two possible sites for each MUP per centre. Overall, results showed that MUP patients were predominantly male, and trunk was the most likely origin, comprising around a third to a half of MUPs across the three cohorts. The remaining MUP inferred sites varied by country. In the Australian cohort, the legs accounted for a third of imputed sites of MUPs, while in the UK and Italian cohorts, the most frequent site was the arms followed by the legs. Our findings suggest the need for regular and thorough skin examination on trunk and limbs, especially in males, to improve early detection of cutaneous melanoma and reduce the risk of metastatic disease at the time of presentation.

Indexed as

MelanomaNeoplasms, Unknown PrimarySkin NeoplasmsAustraliaCutaneous Malignant MelanomaFemaleHumansMaleNeoplasm Staginganatomic sitebody sitescutaneous melanomamelanomaunknown primary

Identifiers

PMID35403698
PMCPMC9325056
OpenAlexW4223497341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.